Combined therapies in a murine model of blastoschizomycosis

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 7, 2007, Pages 2608-2610

  Serena, Carolina ^a   Rodríguez, M Mar ^a   Mariné, Marçal ^a   Pastor, F Javier ^a   Guarro, Josep ^a,b  

^a FACULTAT DE MEDICINA I CIÈNCIES DE LA SALUT   (Spain)

^b UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; FUNGIZONA; MICAFUNGIN; UNCLASSIFIED DRUG; VORICONAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; BLASTOSCHIZOMYCES CAPITATUS; BLASTOSCHIZOMYCOSIS; DRUG EFFICACY; DRUG INDICATION; FUNGAL STRAIN; FUNGUS ISOLATION; MALE; MOUSE; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; YEAST;

AMPHOTERICIN B; ANIMALS; ANTIFUNGAL AGENTS; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FLUCYTOSINE; GEOTRICHOSIS; GEOTRICHUM; HUMANS; IMMUNOCOMPROMISED HOST; LIPOPROTEINS; MALE; MICE; MICE, INBRED STRAINS; MICROBIAL SENSITIVITY TESTS; MYCOSES; PEPTIDES, CYCLIC; PYRIMIDINES; SURVIVAL ANALYSIS; TRIAZOLES; TRICHOSPORON;

EID: 34447288215     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00173-07     Document Type: Article

References (21)

1. Bouza, E., and P. Muñoz. 2004. Invasive infections caused by Blastoschizomycescapitatus and Scedosporium spp. Clin. Microbiol. Infect. 10:76-85.
2. Buchta, V., P. Žák, A. Kohout, and M. Otčenášek. 2001. Disseminated infection of Blastoschizomyces capitatus in a patient with acute myelocytic leukaemia. Mycoses 44:505-512.
3. Christakis, G., S. Perlorentzou, M. Aslanidou, A. Megalakaki, and A. Velegraki. 2005. Fatal Blastoschizomyces capitatus sepsis in a neutropenic patient with acute myeloid leukemia: first documented case from Greece. Mycoses 48:216-220.
4. Diekema, D. J., B. Petroelje, S. A. Messer, R. J. Hollis, and M. A. Pfaller. 2005. Activities of available and investigational antifungal agents against Rhodotorula species. J. Clin. Microbiol. 43:476-478.
5. Eliopoulos, G. M., and R. C. Moellering. 1991. Antimicrobial combinations, p. 432-492. In V. Lorian (ed.), Antibiotics in laboratory medicine, 3rd ed. The Williams & Wilkins Co., Baltimore, MD.
6. Girmenia, C., L. Pagano, B. Martino, D. D'Antonio, R. Fanci, G. Specchia, L. Melillo, M. Buelli, G. Pizzarelli, M. Venditti, and P. Martino. 2005. Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature. J. Clin. Microbiol. 43:1818-1828.
7. Giusiano, G., M. Mangiaterra, V. Garcia Saito, F. Rojas, V. Gomez, and M. C. Diaz. 2006. Fluconazole and itraconazole resistance of yeasts isolated from bloodstream and catheters of hospitalized pediatric patients. Chemotherapy 52:254-259.
8. Graybill, J. R. 2000. The role of murine models in the development of antifungal therapy for systemic mycoses. Drug Resist. Update 3:364-383.
9. Graybill, J. R., R. Bocanegra, L. K. Najvar, D. Loebenberg, and M. F. Luther. 1998. Granulocyte colony-stimulating factor and azole antifungal therapy in murine aspergillosis: role of immune suppression. Antimicrob. Agents Chemother. 42:2467-2473.
10. Graybill, J. R., L. K. Najvar, J. D. Holmberg, and M. F. Luther. 1995. Fluconazole, D0870, and flucytosine treatment of disseminated Candida tropicalis infections in mice. Antimicrob. Agents Chemother. 39:924-929.
11. Johnson, M. D., C. MacDougall, L. Ostrosky-Zeichner, J. R. Perfect, and J. H. Rex. 2004. Combination antifungal therapy. Antimicrob. Agents Chemother. 48:693-715.
12. Martino, R., M. Salavert, R. Parody, J. F. Tomas, R. Camara, L. Vazquez, I. Jarque, E. Pietro, J. L. Sastre, I. Gadea, J. Peman, and J. Sierra. 2004. Blastoschizomyces capitatus infection in patients with leukemia: report of 26 cases. Clin. Infect. Dis. 38:335-341.
13. Martino, P., M. Venditti, A. Micozzi, G. Morace, L. Polonelli, M. P. Mantovani, M. C. Petti, V. L. Burgio, C. Santini, P. Serra, and F. Mandelli. 1990. Blastoschizomyces capitatus: an emerging cause of invasive fungal disease in leukemia patients. Rev. Infect. Dis. 12:570-582.
14. Mathews, M. S., and S. Sen. 1998. Blastoschizomyces capitatus infection after contamination of fluids for intravenous application. Mycoses 41:427-428.
15. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A2, 2nd ed. National Committee for Clinical Laboratory Standards, Wayne, PA.
16. Romano, A., S. Giordano, P. Di Carlo, L. Abbagnato, F. Sapuppo, G. Lázzaro, R. Tetamo, and L. Titone. 2005. Pulmonary infection caused by Blastoschizomyces capitatus. Infez. Med. 13:187-191.
17. Sar, B., D. Monchy, M. Vann, C. Keo, J. L. Sarthou, and Y. Buisson. 2004. Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002. J. Antimicrob. Chemother. 54:563-565.
18. Serena, C., M. Mariné, R. Marimon, F. J. Pastor, and J. Guarro. 2007. Effect of antifungal treatment in a murine model of blastoschizomycosis. Int. J. Antimicrob. Agents 29:79-83.
19. Sugar, A. M., and X. P. Liu. 2001. Efficacy of voriconazole in treatment of murine pulmonary blastomycosis. Antimicrob. Agents Chemother. 45:601-604.
20. Warn, P. A., A. Sharp, J. Mosquera, J. Spickermann, A. Schmitt-Hoffman, M. Heep, and D. W. Denning. 2006. Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus. J. Antimicrob. Chemother. 58:1198-1207.
21. Wills, T. S., A. Degryse, J. Lavina, and J. T. Sinnott. 2004. Blastoschizomyces capitatus pneumonia in an immunocompetent male. South. Med. J. 97:702-704.